Free Trial

Treace Medical Concepts (TMCI) News Today

Treace Medical Concepts logo
$8.47 -0.22 (-2.53%)
As of 03:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Treace Medical Concepts, Inc. stock logo
45,923 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. bought a new stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 45,923 shares of the company's stock, valu
Treace Medical Concepts, Inc. stock logo
Insider Selling: Treace Medical Concepts, Inc. (NASDAQ:TMCI) Insider Sells 50,000 Shares of Stock
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) insider Sean F. Scanlan sold 50,000 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $7.97, for a total transaction of $398,500.00. Following the completion of the sale, the insider now directly owns 364,081 shares of the company's stock, valued at $2,901,725.57. The trade was a 12.07 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Up 4.7% - Should You Buy?
Treace Medical Concepts (NASDAQ:TMCI) Trading 4.7% Higher - Should You Buy?
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Update
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 2,730,000 shares, a growth of 20.8% from the February 13th total of 2,260,000 shares. Currently, 6.1% of the company's stock are sold short. Based on an average daily volume of 373,500 shares, the short-interest ratio is currently 7.3 days.
Treace Medical Concepts, Inc. stock logo
William Blair Investment Management LLC Has $21.87 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
William Blair Investment Management LLC grew its holdings in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 22.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,938,8
Treace Medical Concepts, Inc. stock logo
Truist Financial Has Lowered Expectations for Treace Medical Concepts (NASDAQ:TMCI) Stock Price
Truist Financial dropped their price target on Treace Medical Concepts from $10.00 to $9.50 and set a "hold" rating on the stock in a research note on Thursday.
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's Why
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's Why
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Hold" by Brokerages
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus rating of "Hold" by the seven ratings firms that are presently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and two have assigned a buy
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (NASDAQ:TMCI) Given New $10.00 Price Target at Truist Financial
Truist Financial lifted their price objective on shares of Treace Medical Concepts from $8.40 to $10.00 and gave the company a "hold" rating in a research note on Monday.
Treace Medical Concepts (TMCI) Receives a Hold from Morgan Stanley
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (NASDAQ:TMCI) Announces Earnings Results
Treace Medical Concepts (NASDAQ:TMCI - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. Treace Medical Concepts had a negative net margin of 30.33% and a negative return on equity of 51.12%.
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (TMCI) Expected to Announce Quarterly Earnings on Thursday
Treace Medical Concepts (NASDAQ:TMCI) will be releasing earnings after the market closes on Thursday, February 27, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=435653)
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Hold" by Analysts
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has earned a consensus rating of "Hold" from the seven brokerages that are covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Should You Buy?
Treace Medical Concepts (NASDAQ:TMCI) Shares Gap Up - Here's What Happened
Treace Medical upgraded to Buy from Neutral at BTIG
Positive Report for Treace Medical Concepts (TMCI) from BTIG
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (NASDAQ:TMCI) Stock Rating Upgraded by BTIG Research
BTIG Research raised shares of Treace Medical Concepts from a "neutral" rating to a "buy" rating and set a $16.00 price objective for the company in a research report on Tuesday.
Treace Medical announces completion of first cases using SpeedAkin ACI
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (NASDAQ:TMCI) Shares Up 5.1% - Time to Buy?
Treace Medical Concepts (NASDAQ:TMCI) Trading Up 5.1% - Time to Buy?
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Purchased by Barclays PLC
Barclays PLC boosted its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 352.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 79,696 shares of the company's stock after purchasing an additional 62,073 shares during t
Treace Medical Concepts, Inc. stock logo
JPMorgan Chase & Co. Has $7.32 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
JPMorgan Chase & Co. raised its holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 215.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,262,235 shares of the company's stock after buying an additional
Lake Street Sticks to Its Buy Rating for Treace Medical Concepts (TMCI)
Treace Medical Concepts (TMCI) Receives a Hold from Stifel Nicolaus
Treace Medical Preliminary Q4, FY24 Revenues Beat Expectations; Stock Up
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Up 10.3% - Still a Buy?
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Up 10.3% - What's Next?
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of "Hold" by Brokerages
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has received an average recommendation of "Hold" from the seven analysts that are presently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a hold rating and one has issued a buy rating on the c
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts (NASDAQ:TMCI) Coverage Initiated by Analysts at Lake Street Capital
Lake Street Capital started coverage on Treace Medical Concepts in a research report on Tuesday. They issued a "buy" rating and a $14.50 price target for the company.
Treace Medical Concepts, Inc. stock logo
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Hold" from Brokerages
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) has received a consensus recommendation of "Hold" from the six brokerages that are covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating. The average twelve-month price objective among an
Treace Medical Concepts, Inc. stock logo
Truist Financial Forecasts Strong Price Appreciation for Treace Medical Concepts (NASDAQ:TMCI) Stock
Truist Financial increased their price objective on Treace Medical Concepts from $7.00 to $8.40 and gave the company a "hold" rating in a research report on Wednesday.
Remove Ads
Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.

TMCI Media Mentions By Week

TMCI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TMCI
News Sentiment

0.73

0.63

Average
Medical
News Sentiment

TMCI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TMCI Articles
This Week

8

3

TMCI Articles
Average Week

Remove Ads
Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TMCI) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners